Income statement
USD
Annual
| Metric | 2013 | 2012 |
|---|---|---|
| Revenue | 72 | 60 |
| Gross Profit | -10 | 19 |
| Operating Income | -69 | -9 |
| EBITDA | -69 | -9 |
| Net Income | 46 | -9 |
| EPS (Diluted) | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
VMS Rehab Systems, Inc. (VRSYF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +19.7%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue +19.7%, EPS 0.0%, free cash flow -21.2% with operating margin -95.8% and ROIC 108.3%. Valuation already assumes a fairly strong business story at P/E 0.0 and price/sales 2178.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VRSYF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRSYF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VRSYF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VRSYF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$59.9
-16.4% YoY
FY Net Income
-$8.6
-118.5% YoY
Free Cash Flow
-$0.5
+17.5% YoY
Revenue Growth
+19.7%
EPS Growth
+0.0%
Gross Margin
-14.6%
Net Margin
64.8%
Income statement
USD
| Metric | 2013 | 2012 |
|---|---|---|
| Revenue | 72 | 60 |
| Gross Profit | -10 | 19 |
| Operating Income | -69 | -9 |
| EBITDA | -69 | -9 |
| Net Income | 46 | -9 |
| EPS (Diluted) | — | — |
Balance sheet
USD
| Metric | 2013 | 2012 |
|---|---|---|
| Cash & Equivalents | 0 | 0 |
| Total Assets | 4 | 24 |
| Total Liabilities | 201 | 288 |
| Shareholder Equity | -197 | -264 |
| Total Debt | 134 | 0 |
| Net Debt | 134 | 0 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1
+17.5% YoY
Capital Expenditures
0
Free Cash Flow
1
+17.5% YoY
Key ratios
Gross Margin
-14.6%
Operating Margin
-95.8%
Net Margin
64.8%
ROE
-20.1%
Debt / Equity
-0.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.